Perbedaan Sinar Eka Selaras Tbk. dan UBC Medical Indonesia Tbk.: Sinar Eka Selaras Tbk. diperdagangkan di Rp284 (kapitalisasi pasar 1,47 T, volume 24 jam 501,8 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: Sinar Eka Selaras Tbk. jauh lebih besar — sekitar 2,5× kapitalisasi pasar UBC Medical Indonesia Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (817,3 rb vs 501,8 rb). Mana yang lebih baik tergantung tujuan investasimu.
| ERAL | LABS | |
|---|---|---|
Kapitalisasi Pasar | 1,47 T | 584,6 M |
Volume | 501,8 rb | 817,3 rb |
Lot | 5,02 rb | 8,17 rb |
Perputaran | 141,93 jt | 120,01 jt |
Harga Rata-rata | 282,83 | 146,84 |
Nilai Transaksi | 141,93 jt | 120,01 jt |
Harga Ekuilibrium Indikatif | 284 | 146 |
Volume Ekuilibrium Indikatif | 10 | 59 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Sinar Eka Selaras Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 12 of Myra Yuwono, S.H., dated March 13, 2009. PT Erajaya Swasembada Tbk, an entity incorporated in Indonesia, is the parent company of the Company. PT Eralink International, an entity incorporated inIndonesia, is the ultimate parent of the Company.
Selengkapnya di halaman ERAL →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →